Denali Therapeutics Inc. (DNLI) Profit Margin
Denali Therapeutics Inc. (DNLI) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2018-12-31 | -28.06% |
| 2019-12-31 | -750.81% |
| 2020-12-31 | 21.20% |
| 2021-12-31 | -597.20% |
| 2022-12-31 | -310.28% |
| 2023-12-31 | -43.94% |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How DNLI compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| SPRO | Spero Therapeutics Inc. | 12.83% |
| ACHV | Achieve Life Sciences Inc. | -24.38% |
| IDYA | IDEAYA Biosciences Inc. | -51.99% |
| LXRX | Lexicon Pharmaceuticals Inc. | -101.08% |
| MRNA | Moderna Inc. | -145.16% |
These are five companies in the same sector as DNLI with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Denali Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("DNLI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | DNLI | $20.47 | +3.80% | 2.39M |
| 3 | ||||
| 4 | ||||
| 5 |